Systematic review / meta-analysis / 2010
Evidence is insufficient to reliably recommend Hibiscus sabdariffa for treating primary hypertension in adults.
A systematic review identified four randomized controlled trials totaling 390 patients assessing Hibiscus sabdariffa for primary hypertension. Two trials compared hibiscus to black tea, one to captopril, and one to lisinopril. Hibiscus showed greater blood pressure reduction than black tea but less than ACE inhibitors. However, all studies except one were short term and of poor quality (Jadad score <3), leading authors to conclude that the trials do not provide reliable evidence to support recommending hibiscus for primary hypertension.
- Study type
- Systematic review of randomized controlled trials
- Who was studied
- 390 adult patients with primary hypertension across 4 trials
- What was measured
- Blood pressure reduction and safety
THE PAPER
The effectiveness of Hibiscus sabdariffa in the treatment of hypertension: a systematic review.
Wahabi HA, Alansary LA, Al-Sabban AH, Glasziuo P. Phytomedicine, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.